Temporal changes in resting heart rate and deaths from ischemic heart disease.

CONTEXT Resting heart rate (RHR) has long been recognized as an independent predictor of cardiovascular risk. However, whether temporal changes in RHR influence the risk of death from ischemic heart disease (IHD) in the general population is not known. OBJECTIVE To assess the association of long-term longitudinal changes in RHR with the risk of dying from IHD. DESIGN, SETTINGS, AND PARTICIPANTS A prospective cohort study of 13,499 men and 15,826 women without known cardiovascular disease in Norway. Resting heart rate was measured on 2 occasions around 10 years apart in the Nord-Trøndelag County Health Study. The second RHR measurement was obtained between August 1995 and June 1997, with subsequent mortality follow-up until December 31, 2008. A total of 60 participants were lost to follow-up, all due to emigration from Norway. Using Cox regression analyses, adjusted hazard ratios (AHRs) were estimated of death from IHD related to changes in RHR over time. In a corresponding analysis, death from all causes also was assessed. RESULTS During a mean (SD) of 12 (2) years of follow-up, 3038 people died, and 388 deaths were caused by IHD. An increase in RHR was associated with increased risk of death from IHD. Compared with participants with a RHR of less than 70 beats/min at both measurements (8.2 deaths/10,000 person-years), the AHR was 1.9 (95% CI, 1.0-3.6) for participants with a RHR of less than 70 beats/min at the first measurement but greater than 85 beats/min at the second measurement (17.2 deaths/10,000 person-years). For participants with RHRs between 70 and 85 beats/min at the first measurement and greater than 85 beats/min at the second measurement (17.4 deaths/10,000 person-years), the AHR was 1.8 (95% CI, 1.2-2.8). The association of change in RHR with IHD mortality was not linear (P = .003 for quadratic trend), suggesting that a decrease in RHR showed no general mortality benefit. Excluding the first 3 years of follow-up did not substantially alter the findings. The associations for total mortality were similar but generally weaker than those observed for IHD mortality. CONCLUSION Among men and women without known cardiovascular disease, an increase in RHR over a 10-year period was associated with increased risk of death from IHD and also for all-cause mortality.

[1]  D. Mozaffarian,et al.  Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. , 2006, Journal of the American College of Cardiology.

[2]  X. Jouven,et al.  Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. , 2009, The American journal of cardiology.

[3]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[4]  P. Magnus,et al.  Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. , 1999, Diabetes care.

[5]  Christian Schindler,et al.  Effects of passive smoking on heart rate variability, heart rate and blood pressure: an observational study. , 2007, International journal of epidemiology.

[6]  Stéphane Cook,et al.  High heart rate: a cardiovascular risk factor? , 2006, European heart journal.

[7]  Christian Gieger,et al.  Genome-wide association analysis identifies multiple loci related to resting heart rate. , 2010, Human molecular genetics.

[8]  P. Palatini,et al.  Need for a revision of the normal limits of resting heart rate. , 1999, Hypertension.

[9]  G. Davey Smith,et al.  Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies , 2005, Heart.

[10]  Noël Cameron,et al.  Secular trends , 2018, The International Encyclopedia of Biological Anthropology.

[11]  J. Connell,et al.  Resting Heart Rate Pattern During Follow-Up and Mortality in Hypertensive Patients , 2010, Hypertension.

[12]  Jean-Claude Tardif,et al.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.

[13]  C. Bulpitt,et al.  Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. , 2002, Archives of internal medicine.

[14]  C. Pepine,et al.  Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). , 2007, European heart journal.

[15]  R. Ferrari,et al.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[16]  J. Erikssen,et al.  Resting heart rate in apparently healthy middle-aged men , 1979, European Journal of Applied Physiology and Occupational Physiology.

[17]  A. Dilenarda,et al.  [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[18]  H A Lindberg,et al.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. , 1980, American journal of epidemiology.

[19]  Ian G. Harnik Heart-rate profile during exercise as a predictor of sudden death. , 2005, The New England journal of medicine.

[20]  Anouk Geelen,et al.  Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials , 2005, Circulation.

[21]  Richard B Devereux,et al.  All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. , 2010, European heart journal.

[22]  L. Vatten,et al.  Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway) , 2011, BMC medicine.

[23]  The relationships between self-assessed habitual physical activity and non-invasive measures of cardiac autonomic modulation in young healthy volunteers , 2008, Journal of sports sciences.

[24]  B. Hustvedt,et al.  Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study (HUNT 2) , 2007, European Journal of Epidemiology.

[25]  S. Glantz,et al.  Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. , 1997, Circulation.

[26]  David Litaker,et al.  Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. , 2006, JAMA.

[27]  J. Reidy,et al.  A comparison of measurements of blood pressure, heart-rate and oxygenation during inter-hospital transport of the critically ill , 2005, Intensive Care Medicine.

[28]  Jean-Claude Tardif,et al.  Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.

[29]  M. Gold,et al.  Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial , 2011 .

[30]  R. Ferrari,et al.  Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial , 2008, The Lancet.